352. Chris Kiple, CEO of Solius Labs
Today, I'm joined by Chris Kiple, CEO of Solius Labs.
A decade in development, Solius's FDA-cleared UVB light therapy device personalizes dosage by skin type, aiming to replicate the benefits of sunlight while minimizing carcinogenic risk.
In this episode, we discuss sunlight as a foundational pillar of health and longevity.
We also cover:
Why sun avoidance is deadlier than smoking
Designing a skin scanner for personalized UVB dosing
Moving UVB therapy from clinical dermatology to consumer health
Subscribe to the podcast → insider.fitt.co/podcast
Subscribe to our newsletter →…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.